Biocon Biologicals’ IPO only after integrating Viatris: CEO
The company’s biosimilar arm is looking to complete the process by the end of March
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.